When ebbu Founder and CEO Jon Cooper began to explore the possibilities of a launching a new cannabis business, the seasoned entrepreneur’s first thought on the plant’s chemistry was: “We’re dealing with lots of chaos here.”
ebbu’s approach is to dial in the best formulations of a number of cannabinoids and terpenes, to take advantage of the entourage effect and produce the most effective, consistent mood sensations and experiences, as well as health benefits.
The progress of cannabis research has been hampered in the U.S. by the federal status of marijuana. As we’ve learned at our ebbu laboratory headquartered in Colorado, having access to a variety of strains is crucial to conducting research.
ebbu’s wide-ranging mission to propel cannabis science and unlock the secrets of the plant’s fundamental compounds starts with revolutionary hemp cultivation.
Colorado’s cannabis legalization forever changed one young scientist’s career path. And in the past few years, Robert Roscow Jr. has been riding the bleeding edge of cannabis science as one of the first researchers to apply genome editing techniques to Cannabis sativa L.
Cannabis has long been used as medicine—going back at least 6,000 years around the world.
Researchers report that records of cannabis use date to 2,700 years ago in Ancient China, where it is believed to have been used as an anesthetic. It played a role in Ayurvedic medicine in India, and its use was also documented in Egyptian papyri.
This might just be the best job title ever: Cannabis product tester.
Even better, it’s a real opportunity from Colorado-based cannabis technology lab ebbu, which has spent the last two years conducting clinical research involving panels of adults trying out new products from the company’s high-science development laboratory.
Cannabis researchers working to take the mystery out of cannabis as medicine are digging deeper into the chemical structure of this complex plant, discovering more about the true source of its seemingly magical medical properties. Along the way, they have uncovered an interesting trick—the human body is designed to interact with cannabis, in the form of compounds in the plant known as cannabinoids.
Dr. Brian Reid, ebbu’s Chief Science Officer, is one of the leading minds in the cannabis industry. Dr. Reid oversees all of the research and development that takes place at ebbu, including chemistry, chromatography, cellular pharmacology, human pharmacology and genetics.
We’ve been approached by lots of folks over the last month asking us, “Why the heck did you give up your license to work with marijuana and THC?” On the surface, we understand that it seems completely unnatural to so happily give up something that we fought so hard to get and maintain over the last few years.
When ebbu founder Jon Cooper first looked at the cannabis industry, one of his early qualms was that he didn’t trust cannabis products in the same way he understood alcohol products.